Discover
KLRS
Kalaris Therapeutics Inc
4.08
1 x 3.94
2 x 4.14
bid
ask
+
0.14
3.55%
12:32 PM
timesize
| Ytd | -51.66% | |
| 1y | 53.38% |
3.94
day range
4.08
2.14
52 week range
11.88
| Open | 3.95 | Prev Close | 3.94 | Low | 3.94 | High | 4.08 | Mkt Cap | 89.06M |
| Vol | 7.30K | Avg Vol | 267.23K | EPS | -2.15 | P/E | -1.90 | Forward P/E | N/A |
| Beta | 0.20 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 4.30 | 200-d Avg | 6.52 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 11.83M | ||
| Research and Development Expense | 7.57M | ||
| Selling, General and Administrative Expense | 4.26M | ||
| Operating Income | -11.83M | ||
| Net Income | -10.86M | ||
| Net Income Common Stock | -10.86M | ||
| Net Income Common Stock (USD) | -10.86M | ||
| Consolidated Income | -10.86M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | -10.86M | ||
| Earning Before Interest & Taxes (USD) | -10.86M | ||
| Weighted Average Shares | 23.72M | ||
| Weighted Average Shares Diluted | 23.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 34.93M | ||
| Cash and Equivalents (USD) | 34.93M | ||
| Investments | 70.44M | ||
| Investments Current | 62.79M | ||
| Investments Non-Current | 7.65M | ||
| Current Assets | 98.47M | ||
| Property, Plant & Equipment Net | 1.43M | ||
| Total Assets | 109.81M | ||
| Debt Current | 317.00K | ||
| Total Debt | 1.41M | ||
| Current Liabilities | 8.08M | ||
| Debt Non-Current | 1.09M | ||
| Total Liabilities | 41.25M | ||
| Accumulated Retained Earnings (Deficit) | -170.85M | ||
| Accumulated Other Comprehensive Income | -49.00K | ||
| Shareholders Equity | 68.56M | ||
| Shareholders Equity (USD) | 68.56M | ||
| Assets Non-Current | 11.34M | ||
| Total Debt (USD) | 1.41M | ||
| Liabilities Non-Current | 33.17M | ||
| Trade and Non-Trade Payables | 905.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 52.00K | ||
| Net Cash Flow from Financing | -1.69M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -63.63M | ||
| Issuance (Purchase) of Equity Shares | 74.00K | ||
| Net Cash Flow from Investing | -50.35M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -50.35M | ||
| Net Cash Flow from Operations | -11.58M | ||
| Share Based Compensation | 580.00K | ||